[144 Pages Report] The global interventional radiology products market is expected to reach USD 8.02 Billion by 2021 from USD 6.35 Billion in 2016, at a CAGR of 4.8%. The major factors driving the growth of this market are rising incidence of chronic diseases, rising geriatric population, and increasing demand for minimally invasive surgeries.

The global market is broadly classified into type, procedure, application, and region.

Based on type, the market is segmented into stents, catheters, IVC filters, hemodynamic flow alteration devices, angioplasty balloons, thrombectomy systems, embolization devices, needle biopsy, and accessories.

Based on procedure, the market is segmented into angioplasty, angiography, embolization, thrombolysis, biopsy & drainage, vertebroplasty, nephrostomy, and other applications.

Based on application, the market is segmented into cardiology, urology & nephrology, oncology, gastroenterology, neurology, orthopedics, and other applications.

Based on region, the market is segmented into North America, Europe, Asia, and Rest of the World (RoW).

The major players in the interventional radiology products market include Abbott Vascular (U.S.), Boston Scientific Corporation (U.S.), Medtronic plc (Ireland), Cardinal Health (U.S.), B. Braun Melsungen AG (Germany), C.R Bard (U.S.), Biosensor International Group Ltd. (Singapore), Stryker Corporation (U.S.), Terumo Corporation (Japan), and Cook Medical Inc. (U.S.).

Target Audience for this Report:

Interventional radiology product manufacturers

Interventional radiology product distributors

Healthcare institutions (hospitals, medical schools, group practices, individual surgeons, and governing bodies)

Various research and consulting companies

Various research associations related to interventional radiology

Value Addition for the Buyer:

This report aims to provide detailed insights into the global interventional radiology products industry. It provides valuable information on the type, procedure, application, and region in the market. Furthermore, the information for these segments, by region, is also presented in this report. Leading players in the market are profiled to study their product offerings and understand the strategies undertaken by them to be competitive in this market.

The above-mentioned information would benefit the buyer by helping them understand the market dynamics. In addition, the forecasts provided in the report will enable firms to understand the trends in this market and better position themselves to capitalize the growth opportunities.

Scope of the Report:

To know about the assumptions considered for the study, download the pdf brochure

This report categorizes the interventional radiology products market into the following segments:

Interventional Radiology Products Market, by Type

Catheters Diagnostics Catheters Therapeutics Catheters

Stents Diagnostics Stents Therapeutics Stents

Inferior Vena Cava (IVC) Filters

Hemodynamic Flow Alteration Devices

Angioplasty Balloons

Thrombectomy Systems

Embolization Devices

Biopsy Needles

Accessories Contrast Media Guidewires Balloon Inflation Devices Other Accessories

Other Types (Bone Cement, Nephrostomy Tubes, and Gastrostomy Tubes)

Interventional Radiology Products Market, by Procedure

Angioplasty

Angiography

Embolization

Thrombolysis

Biopsy & Drainage

Vertebroplasty

Nephrostomy

Other Procedures (Biliary Drainage, Fallopian Tube Recanalization, Cholecystostomy, and Procedures for Carotico Cavernous Fistula Treatment)

Interventional Radiology Products Market, by Application

Cardiology

Urology & Nephrology

Oncology

Gastroenterology

Neurology

Orthopedics

Other Applications (Pulmonary and Gynaecology)

Interventional Radiology Products Market, by Region

North America U.S. Canada

Europe Germany France Italy U.K. RoE

Asia

Rest of the World (RoW)

Customization Options:

Company Information: Detailed company profiles of five or more market players

Opportunities Assessment: A detailed report underlining the various growth opportunities presented in the market

The interventional radiology products market is expected to reach USD 8.02 Billion by 2021 from USD 6.35 Billion in 2016, at a CAGR of 4.8%. This market is segmented based on type, procedure, application, and region.

The major factors driving the growth of this market are rising incidence of chronic diseases, rising geriatric population, and increasing demand for minimally invasive surgeries. However, new players in the interventional radiology sector face significant entry barriers; this is a key challenge in the market.

Based on type, the market is segmented into stents, catheters, IVC filters, hemodynamic flow alteration devices, angioplasty balloons, thrombectomy systems, embolization devices, biopsy needles, and accessories. In 2016, the stents segment is expected to dominate the global market. The key factors driving the growth of the interventional radiology stents market are the growing geriatric population and increasing incidence of cardiovascular diseases around the world.

Based on procedure, the market is segmented into angioplasty, angiography, embolization, thrombolysis, biopsy & drainage, vertebroplasty, nephrostomy, and other applications. In 2016, the angiography segment is expected to account for the largest share of this market. The growing demand for minimally invasive procedures and rising geriatric population are the key factors driving market growth in this segment.

Based on application, the market is segmented into cardiology, urology & nephrology, oncology, gastroenterology, neurology, orthopedics, and other applications. The oncology segment is expected to grow at the highest CAGR during the forecast period. The major factors driving the growth of this market segment are the increasing incidence of cancer and rising demand for minimally invasive procedures.

The global interventional radiology products market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). North America will continue to dominate the global market in the forecast period. However, Asia is expected to witness the highest CAGR, with the growth in this market centred at China, Japan, and India. The increasing prevalence of chronic diseases and growing geriatric population in Asia are driving the growth of this region.

Key players in the interventional radiology products market include Abbott Vascular (U.S.), Boston Scientific Corporation (U.S.), Medtronic plc (Ireland), Cardinal Health (U.S.), B. Braun Melsungen AG (Germany), C.R Bard (U.S.), Biosensor International Group Ltd. (Singapore), Stryker Corporation (U.S.), Terumo Corporation (Japan), and Cook Medical Inc. (U.S.).

To speak to our analyst for a discussion on the above findings, click Speak to Analyst